Literature DB >> 26101198

Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease.

Ravindran Kumaran1, Mark R Cookson2.   

Abstract

In the past few years, there have been a large number of genes identified that contribute to the lifetime risk of Parkinson's disease (PD). Some genes follow a Mendelian inheritance pattern, but others are risk factors for apparently sporadic PD. Here, we will focus on those genes nominated by genome-wide association studies (GWAS) in sporadic PD, with a particular emphasis on genes that overlap between familial and sporadic disease such as those encoding a-synuclein (SNCA), tau (MAPT), and leucine-rich repeat kinase 2 (LRRK2). We will advance the view that there are likely relationships between these genes that map not only to neuronal processes, but also to neuroinflammation. We will particularly discuss evidence for a role of PD proteins in microglial activation and regulation of the autophagy-lysosome system that is dependent on microtubule transport in neurons. Thus, there are at least two non-mutually exclusive pathways that include both non-cell-autonomous and cell-autonomous mechanisms in the PD brain. Collectively, these data have highlighted the amount of progress made in understanding PD and suggest ways forward to further dissect this disorder. Published by Oxford University Press 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26101198      PMCID: PMC4571999          DOI: 10.1093/hmg/ddv236

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  130 in total

1.  Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein.

Authors:  He-Jin Lee; Ji-Eun Suk; Eun-Jin Bae; Jung-Ho Lee; Seung R Paik; Seung-Jae Lee
Journal:  Int J Biochem Cell Biol       Date:  2008-01-20       Impact factor: 5.085

Review 2.  Glucocerebrosidase, a new player changing the old rules in Lewy body diseases.

Authors:  Na-Young Yang; Yu-Na Lee; He-Jin Lee; Yoon Suk Kim; Seung-Jae Lee
Journal:  Biol Chem       Date:  2013-07       Impact factor: 3.915

3.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.

Authors:  Alfredo Ramirez; André Heimbach; Jan Gründemann; Barbara Stiller; Dan Hampshire; L Pablo Cid; Ingrid Goebel; Ammar F Mubaidin; Abdul-Latif Wriekat; Jochen Roeper; Amir Al-Din; Axel M Hillmer; Meliha Karsak; Birgit Liss; C Geoffrey Woods; Maria I Behrens; Christian Kubisch
Journal:  Nat Genet       Date:  2006-09-10       Impact factor: 38.330

4.  MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease.

Authors:  I Kurkowska-Jastrzebska; A Wrońska; M Kohutnicka; A Członkowski; A Członkowska
Journal:  Acta Neurobiol Exp (Wars)       Date:  1999       Impact factor: 1.579

5.  Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.

Authors:  Günter U Höglinger; Nadine M Melhem; Dennis W Dickson; Patrick M A Sleiman; Li-San Wang; Lambertus Klei; Rosa Rademakers; Rohan de Silva; Irene Litvan; David E Riley; John C van Swieten; Peter Heutink; Zbigniew K Wszolek; Ryan J Uitti; Jana Vandrovcova; Howard I Hurtig; Rachel G Gross; Walter Maetzler; Stefano Goldwurm; Eduardo Tolosa; Barbara Borroni; Pau Pastor; Laura B Cantwell; Mi Ryung Han; Allissa Dillman; Marcel P van der Brug; J Raphael Gibbs; Mark R Cookson; Dena G Hernandez; Andrew B Singleton; Matthew J Farrer; Chang-En Yu; Lawrence I Golbe; Tamas Revesz; John Hardy; Andrew J Lees; Bernie Devlin; Hakon Hakonarson; Ulrich Müller; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-06-19       Impact factor: 38.330

6.  Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models.

Authors:  Tetyana Duka; Valeriy Duka; Jeffrey N Joyce; Anita Sidhu
Journal:  FASEB J       Date:  2009-04-15       Impact factor: 5.191

7.  LRRK2 phosphorylates novel tau epitopes and promotes tauopathy.

Authors:  Rachel M Bailey; Jason P Covy; Heather L Melrose; Linda Rousseau; Ruth Watkinson; Joshua Knight; Sarah Miles; Matthew J Farrer; Dennis W Dickson; Benoit I Giasson; Jada Lewis
Journal:  Acta Neuropathol       Date:  2013-10-11       Impact factor: 17.088

8.  Variation in tau isoform expression in different brain regions and disease states.

Authors:  Elisa Majounie; William Cross; Victoria Newsway; Allissa Dillman; Jana Vandrovcova; Christopher M Morris; Michael A Nalls; Luigi Ferrucci; Michael J Owen; Michael C O'Donovan; Mark R Cookson; Andrew B Singleton; Rohan de Silva; Huw R Morris
Journal:  Neurobiol Aging       Date:  2013-02-19       Impact factor: 4.673

9.  Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip.

Authors:  Chris C A Spencer; Zhan Su; Peter Donnelly; Jonathan Marchini
Journal:  PLoS Genet       Date:  2009-05-15       Impact factor: 5.917

10.  Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects.

Authors:  Nikolaos A Patsopoulos; Lisa F Barcellos; Rogier Q Hintzen; Catherine Schaefer; Cornelia M van Duijn; Janelle A Noble; Towfique Raj; Pierre-Antoine Gourraud; Barbara E Stranger; Jorge Oksenberg; Tomas Olsson; Bruce V Taylor; Stephen Sawcer; David A Hafler; Mary Carrington; Philip L De Jager; Paul I W de Bakker
Journal:  PLoS Genet       Date:  2013-11-21       Impact factor: 5.917

View more
  40 in total

Review 1.  Parkin and PINK1 functions in oxidative stress and neurodegeneration.

Authors:  Sandeep K Barodia; Rose B Creed; Matthew S Goldberg
Journal:  Brain Res Bull       Date:  2016-12-23       Impact factor: 4.077

Review 2.  Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease.

Authors:  D James Surmeier; Glenda M Halliday; Tanya Simuni
Journal:  Exp Neurol       Date:  2017-08-02       Impact factor: 5.330

Review 3.  Selective neuronal vulnerability in Parkinson disease.

Authors:  D James Surmeier; José A Obeso; Glenda M Halliday
Journal:  Nat Rev Neurosci       Date:  2017-01-20       Impact factor: 34.870

Review 4.  The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease.

Authors:  Yan Shen; Xingfang Guo; Chao Han; Fang Wan; Kai Ma; Shiyi Guo; Luxi Wang; Yun Xia; Ling Liu; Zhicheng Lin; Jinsha Huang; Nian Xiong; Tao Wang
Journal:  Cell Mol Life Sci       Date:  2017-06-16       Impact factor: 9.261

5.  Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.

Authors:  Joanna A Korecka; Elizabeth B Moloney; Ruben Eggers; Barbara Hobo; Sanny Scheffer; Nienke Ras-Verloop; R Jeroen Pasterkamp; Dick F Swaab; August B Smit; Ronald E van Kesteren; Koen Bossers; Joost Verhaagen
Journal:  J Neurosci       Date:  2017-08-21       Impact factor: 6.167

Review 6.  Proteomics; applications in familial Parkinson's disease.

Authors:  Yan Li; Mark R Cookson
Journal:  J Neurochem       Date:  2019-07-09       Impact factor: 5.372

Review 7.  Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Authors:  J A Obeso; M Stamelou; C G Goetz; W Poewe; A E Lang; D Weintraub; D Burn; G M Halliday; E Bezard; S Przedborski; S Lehericy; D J Brooks; J C Rothwell; M Hallett; M R DeLong; C Marras; C M Tanner; G W Ross; J W Langston; C Klein; V Bonifati; J Jankovic; A M Lozano; G Deuschl; H Bergman; E Tolosa; M Rodriguez-Violante; S Fahn; R B Postuma; D Berg; K Marek; D G Standaert; D J Surmeier; C W Olanow; J H Kordower; P Calabresi; A H V Schapira; A J Stoessl
Journal:  Mov Disord       Date:  2017-09       Impact factor: 10.338

Review 8.  Microglia Function in the Central Nervous System During Health and Neurodegeneration.

Authors:  Marco Colonna; Oleg Butovsky
Journal:  Annu Rev Immunol       Date:  2017-02-09       Impact factor: 28.527

Review 9.  The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research.

Authors:  Rebekah G Langston; Iakov N Rudenko; Mark R Cookson
Journal:  Biochem J       Date:  2016-02-01       Impact factor: 3.857

10.  Differences in Stability, Activity and Mutation Effects Between Human and Mouse Leucine-Rich Repeat Kinase 2.

Authors:  Rebekah G Langston; Iakov N Rudenko; Ravindran Kumaran; David N Hauser; Alice Kaganovich; Luis Bonet Ponce; Adamantios Mamais; Kelechi Ndukwe; Allissa A Dillman; Amr M Al-Saif; Aleksandra Beilina; Mark R Cookson
Journal:  Neurochem Res       Date:  2018-10-05       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.